Wegovy (semeglutide ) injections for weightloss on the NHS

Semaglutide (Wegovy) launched in the UK on 4 September and is available on the NHS as an option for weight management in line with NICE guidance, alongside a reduced-calorie diet and increased physical activity.

Patients are eligible for treatment within a specialist weight management service if they have at least one weight-related comorbidity, such as hypertension or cardiovascular disease, and either a BMI of at least 35 or a BMI of 30 to 34.9, provided they meet the criteria for referral to specialist weight management services, including that conventional treatment has been unsuccessful.

If you meet the criteria and wish to discuss with your GP please call the surgery to arrange a routine appointment.

For further information please follow the link below-

Please click here for more information